How many drugs were approved in 2003?

Drug Landscape tracks 49 drug approvals with a first_approval_date in 2003 (FDA, EMA, MHRA, PMDA combined). The full list is on this page, each linked to its primary regulatory source.

Which patents expired in 2003?

No tracked patents have an expiry date in 2003.

What Phase 3 readouts happened in 2003?

No Phase 3 trials have completion dates in 2003.

Where does this data come from?

Approvals from FDA Drugs@FDA, EMA EPAR, MHRA, and PMDA. Patent data from FDA Orange Book + USPTO PAIR. Trial data from ClinicalTrials.gov. Updates daily.

2003 in pharma — approvals, patent cliffs, Phase 3 readouts

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Every FDA approval, patent expiry, and pivotal Phase 3 readout tracked for 2003: 49 approvals, 0 patent expiries, 0 Phase 3 milestones.

2001 2002 2003 2004 2005

FDA / EMA / MHRA approvals (49)

2004 — Pentetate Calcium Trisodium · Hameln · Nephrology
2004 — TRYPAN BLUE
2004 — Vidaza · Bristol-Myers Squibb · Oncology
2004 — Tindamax · Mission Pharma · Infectious Disease
2004 — MELAGATRAN · Hematology
2004 — TIOTROPIUM
2004 — Macugen · Valeant Pharms Llc · Ophthalmology
2004 — Nutrestore · Emmaus Medcl · Hematology
2004 — Alimta · Actavis · Oncology
2004 — Detapac · Nephrology
2004 — Mycophenolate · Novartis · Immunology
2004 — SYNTHETIC CONJUGATED ESTROGENS, B
2004 — Bevacizumab · Roche · Oncology
2004 — Ketek · Sanofi · Infectious Disease
2004 — LANTHANUM CARBONATE
2004 — Sensipar · Amgen · Oncology
2004 — Excedrin Extra Strength Pain Reliever · Haleon Us Holdings · Immunology
2004 — Lunesta · Waylis · Neuroscience
2004 — Vesicare · Astellas Pharma · Urology
2004 — Tarceva · Osi Pharms · Oncology
2004 — Clolar · Sanofi · Oncology
2004 — Apokyn · Mdd Us · Neuroscience
2004 — TECHNETIUM TC 99M FANOLESOMAB
2004 — AZACITIDINE
2004 — Halflytely · Braintree · Neuroscience
2004 — PEMETREXED
2004 — CINACALCET HYDROCHLORIDE
2004 — PEMETREXED DISODIUM
2004 — Erbitux · Imclone · Oncology
2004 — ACAMPROSATE CALCIUM
2004 — CETUXIMAB
2004 — ERLOTINIB
2004 — OMEGA-3-ACID ETHYL ESTERS
2004 — Tysabri · Biogen Idec · Immunology
2004 — Spiriva · Boehringer Ingelheim · Respiratory
2004 — Imovane · Sunovion Pharms Inc · Neuroscience
2004 — Sanctura · AbbVie · Urology
2004 — ZICONOTIDE ACETATE
2004 — Kepivance · Biovitrum Ab · Immunology
2004 — Multihance · Bracco · Other
2004 — Macugen · Bausch Health · Ophthalmology
2004 — Avastin · Roche · Oncology
2004 — Campral · Allergan/AbbVie · Neuroscience
2004 — Enablex · AbbVie · Urology
2004 — Apidra · Sanofi · Metabolic
2004 — SOLIFENACIN SUCCINATE
2004 — Luveris · Merck KGaA · Other
2004 — TRYPAN BLUE FREE ACID
2004 — DARIFENACIN HYDROBROMIDE

Patent expiries (0)

No entries tracked.

Phase 3 readouts (0)

No entries tracked.